Comparison Between Pupillometry and the Numerical Rating Scale
1 other identifier
interventional
320
1 country
1
Brief Summary
Given the difficulties encountered with subjective pain assessment tools, one of the ideas for reducing the occurrence of insufficient analgesia administration in the emergency department is to find a tool capable of measuring pain without requiring the patient's participation, and which could be integrated into the systematic measurement of the 4 other vitals. An interesting idea is the measurement of pupillary diameter and its reflex variations by a portable pupillometer. Indeed, the diameter of the pupil (DP) reflects the constant interactions between the sympathetic and parasympathetic systems at the level of the iris muscles. Pupillometry measures the change in pupillary diameter and allows the performance of three dynamic tests useful in the assessment of pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2021
CompletedFirst Submitted
Initial submission to the registry
August 10, 2021
CompletedFirst Posted
Study publicly available on registry
August 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 4, 2022
CompletedAugust 25, 2021
August 1, 2021
12 months
August 10, 2021
August 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome will be the correlation between the pupillometry values and those obtained by the numerical pain rating scale with a correlation coefficient of 0.78.
1 minute
Secondary Outcomes (6)
The evolution of the Pupillary Unrest in Ambient Light depending on the type of opioid (morphine versus weak opioid like tramadol) received by the patient.
one hour
The endpoint will be the evaluation of the performance of pupillometry to predict the occurrence of Numerical Rating Scale (NRS) ≥ 4 using the ROC curve (AUC).
1 minute
The correlation of the pupillometric parameters with the level of anxiety quantified by a numeric scale next to 1 (not anxious) to 10 (maximum level of anxiety).
1 minute
The correlation between the initial measurement of PUAL and the analgesic response to an opioid medication.
one hour
The correlation between the pain measurements obtained by the reception nurse and that obtained by the patient.
2 minutes
- +1 more secondary outcomes
Study Arms (1)
Diagnostic Test: pupillometry
EXPERIMENTALInterventions
Step 1: The triage will be carried out by the nurse. The nurse will then perform a self-assessment of the patient's pain using a simple verbal scale. The nurse will then record the patient's self-assessment of his pain using the numeric scale for pain. Step 2: Immediately after this first assessment, eligible patients will be approached by the study investigator to be included in the study. Step 3: If the patient gives informed consent, the study investigator will perform * The quantification of their anxiety * An assessment of pain by a NeuroLight videopupillometer (iDmed, Marseille, France) using two dynamic tests, the Pupillary Unrest in Ambient Light (PUAL) and the pupillary light reflex. Step 4: One hour after the triage, a second pain assessment will be performed. Step 5: The same pupillometry measurements will be taken immediately after the nurse has assessed the pain.
Eligibility Criteria
You may qualify if:
- All patients presenting to the emergency room, aged 18 years or over, able to communicate, with hemodynamic and respiratory stability, are eligible.
You may not qualify if:
- \- Refusal to participate in the study; refusal to sign informed consent.
- Consent impossible to obtain (cognitive disorders, language barrier…).
- Patient taking immediate-release opioid medication (last dose within the last 12 hours).
- Patient taking prolonged-release opioid medication (last dose within the last 24 hours).
- Basic treatment with a dopaminergic D2 antagonist (antipsychotic drugs).
- Basic treatment with dopamine antagonist antiemetic medication (metoclopramide (T1/2 5-6h), domperidone (T1/2 7-9h), alizapride (T1/2 3h)) within the last 12 hours.
- Patient taking clonidine (last dose within the last 24 hours).
- Use of topical ocular drugs modifying pupillary parameters in the last 24 hours.
- Bilateral eye surgery modifying the possibilities of variation in pupillary diameter bilaterally.
- Parkinson's or Alzheimer's disease at a dysautonomic stage.
- Admission to the emergency room for acute ocular pathology.
- History of diabetes at a dysautonomic stage.
- History of alcoholism at a dysautonomic stage.
- History of glaucoma.
- Pregnant patient with preeclampsia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
Related Publications (1)
Gregoire C, Charier D, de Bergeyck R, Mouraux A, Van Ouytsel F, Lambert R, Zhou N, Lavand'homme P, Penaloza A, Pickering G. Comparison between pupillometry and numeric pain rating scale for pain assessments in communicating adult patients in the emergency department. Eur J Pain. 2023 Sep;27(8):952-960. doi: 10.1002/ejp.2137. Epub 2023 Jun 11.
PMID: 37303073DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2021
First Posted
August 25, 2021
Study Start
August 4, 2021
Primary Completion
August 1, 2022
Study Completion
August 4, 2022
Last Updated
August 25, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share